Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Status:
Completed
Trial end date:
2002-08-28
Target enrollment:
Participant gender:
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were
destroyed by the chemotherapy or radiation therapy used to kill tumor cells. Sometimes the
transplanted cells are rejected by the body's normal tissues. Transplanting donated cells
that have been treated with psoralen may prevent this from happening.
PURPOSE: Phase I trial to study the effectiveness of chemotherapy, radiation therapy, and
psoralen-treated donor cells in treating patients who are undergoing peripheral stem cell
transplantation for hematologic cancer.